COVID-19 vaccine | Is the Moderna and NIH Partnership 'Rotten To The Core'?

Share the News

Ben Swann takes a look at the highly unusual timeline by which Moderna Therapeutics is developing its COVID-19 virus vaccine

Now, four scientists with the NIH claim they hold partial patent rights on that vaccine and stand to make up to $150,000 per year.

Meanwhile, as Moderna’s stock price continues to soar, five top executives have sold off $89 million dollars worth of shares, even as the company continues to bypass standard vaccine protocols in the development of its COVID vaccine

Subscribe to RT!


Check out

Like us on Facebook
Follow us on VK
Follow us on Twitter
Follow us on Instagram
Follow us on Soundcloud

#RT (Russia Today) is a global #news network broadcasting from Moscow, London, Paris and Washington studios to over 100 countries. RT is the first news channel to break the 1 billion YouTube views benchmark.